Beposone shows nasal symptom improvement in Phase 2 study
Bepotastine besilate is a non-sedating, antagonist of the histamine H1 receptor that acts by suppressing the migration of eosinophils into inflamed tissues. The Phase 2 randomised placebo-controlled parallel-group